Jan 5, 2017 Roth Capital Partners Acts as Sole Book-Running Manager for SenesTech, Inc. (NASDAQ: SNES) in its $15 Million IPO Roth Capital Partners
Jan 5, 2017 Roth Capital Partners Acts as Sole Book-Running Manager and Sole Placement Agent For RedHill Biopharma Ltd. (RDHL) in its concurrent $24.4 Million Follow-On and $15 Million Registered Direct Roth Capital Partners
Jan 5, 2017 Roth Capital Partners Acts as Lead U.S. Placement Agent for Pharming Group N.V. (EURONEXT: PHARM) in its €104 Million Financing Roth Capital Partners
Jan 4, 2017 Roth Capital Partners Acts as Sole Book-Running Manager for BioPharmX Corporation (NYSE:BPMX) in its $13 Million Follow-On Roth Capital Partners
Dec 27, 2016 Roth Capital Partners Acts as Sole Book-Running Manager for LightPath Technologies, Inc. (NASDAQ:LPTH) in a $9.7 Million Follow-On and renders a Fairness Opinion in connection with the acquisition of ISP Optics Roth Capital Partners
Dec 5, 2016 Roth Capital Partners Acts as Sole Manager for Cherokee Inc. (CHKE) in its $40 Million Follow-On Roth Capital Partners
Nov 29, 2016 Roth Capital Partners to Host New Industrials Corporate Access Day in New York City on December 13, 2016 Business Wire
Nov 4, 2016 Roth Capital Partners to Host Innovations in Oncology Corporate Access Day in New York on November 17, 2016 Business Wire